get a key
steadybase-$ company ARTL
account_id none on file
legal_name Artelo Biosciences, Inc.
ticker ARTL
cik 1621221
domain artelobio.com
entry_point_account_id none on file
name Artelo Biosciences Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 4 executives 1 family 0
why_nownone on file
callsnone on file
filings
On May 12, 2021, the Company entered into a lease arrangement for office space in the U.S. On March 6, 2024, the Company entered into an amended agreement with the landlord to extend the lease commencing in September 2024, and effective until August 2027.

filing / Aug 12, 2026 / receipt

Mark Spring was appointed chief financial officer, treasurer, principal financial officer and principal accounting officer in November 2025.

filing / Jun 5, 2026 / receipt

Spring joined us as Chief Financial Officer and Treasurer effective November 1, 2025. (2) In accordance with SEC rules, the amounts shown reflect the aggregate grant date fair value of stock awards granted to Non-Employee Directors during the applicable year, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (“FASB ASC 718”).

filing / Jun 5, 2026 / receipt

We are embracing technology to provide expanded access, improved communication, reduced environmental impact and cost savings for our stockholders and the Company.

filing / Jun 5, 2026 / receipt

executives
Mark Spring Chief Financial Officer - receipt
familynone on file
upcoming
2026-11-11 earnings call scheduled ir
changes
2025-10-27 Chief Financial Officer, appointed sec_8k
2017-04-07 President, departed sec_8k
mcp_package_hint
steadybase-$